UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 306

Sortiert nach

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

Journal of clinical oncology, 2017-09, Vol.35 (27), p.3097-3104

2017

Volltextzugriff (PDF)

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

The Lancet (British edition), 2016-03, Vol.387 (10024), p.1163-1177

2016

Volltextzugriff (PDF)

Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis

European urology, 2019-07, Vol.76 (1), p.115-124

2019

Volltextzugriff (PDF)

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

The lancet oncology, 2016-02, Vol.17 (2), p.243-256

2016

Volltextzugriff (PDF)

Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer

European urology, 2019-12, Vol.76 (6), p.719-728

2019

Volltextzugriff (PDF)

Importance of non‐regional lymph nodes in assigning risk in primary metastatic prostate cancer

BJU international, 2019-01, Vol.123 (1), p.65-73

2019

Volltextzugriff (PDF)

Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer

Cell reports (Cambridge), 2018-12, Vol.25 (12), p.3504-3518.e6

2018

Volltextzugriff (PDF)

FTIR microscopy of biological cells and tissue: data analysis using resonant Mie scattering (RMieS) EMSC algorithm

Analyst (London), 2012-03, Vol.137 (6), p.137-1377

2012

Volltextzugriff (PDF)

Following the Narrow Path

European urology, 2023-01, Vol.83 (1), p.27-28

Clarke, Noel W.

2023

Volltextzugriff (PDF)

Measurement of elastic properties of prostate cancer cells using AFM

Analyst (London), 2008-01, Vol.133 (11), p.1498-1500

2008

Volltextzugriff (PDF)

Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer

Journal of clinical oncology, 2011-02, Vol.29 (6), p.733-738

2011

Volltextzugriff (PDF)

Automated quantitative high-throughput multiplex immunofluorescence pipeline to evaluate OXPHOS defects in formalin-fixed human prostate tissue

Scientific reports, 2022-04, Vol.12 (1), p.6660-15, Article 6660

2022

Volltextzugriff (PDF)

This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols

Trials, 2019-05, Vol.20 (1), p.264-13, Article 264

2019

Volltextzugriff (PDF)

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial

Trials, 2012-09, Vol.13 (1), p.168-168, Article 168

2012

Volltextzugriff (PDF)

Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer

Cancers, 2021-11, Vol.13 (22), p.5830

2021

Volltextzugriff (PDF)

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)

The lancet oncology, 2013-04, Vol.14 (4), p.306-316

2013

Volltextzugriff (PDF)

Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study

Radiotherapy and oncology, 2018-08, Vol.128 (2), p.357-363

2018

Volltextzugriff (PDF)

Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study

BMC nephrology, 2020-05, Vol.21 (1), p.202-202, Article 202

2020

Volltextzugriff (PDF)

Assessment of paraffin removal from prostate FFPE sections using transmission mode FTIR-FPA imaging

Analytical methods, 2014-01, Vol.6 (4), p.1028-1035

2014

Volltextzugriff (PDF)

Accumulation of copy number alterations and clinical progression across advanced prostate cancer

Genome medicine, 2022-09, Vol.14 (1), p.102-102, Article 102

2022

Volltextzugriff (PDF)

Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy

Journal of lipid research, 2007-08, Vol.48 (8), p.1846-1856

2007

Volltextzugriff (PDF)

Reply to Lin Ding, Bin Yang, and Xudong Yao’s Letter to the Editor re: Fred Saad, Noel W. Clarke, Mototsugu Oya, et al. Olaparib plus Abiraterone Versus Placebo plus Abiraterone in Metastatic Castration-resistant Prostate Cancer (PROpel): Final Prespecified Overall Survival Results of a Randomised, Double-blind, Phase 3 Trial. Lancet Oncol 2023;24:1094–108

European urology, 2024-06, Vol.85 (6), p.e178-e179

2024

Volltextzugriff (PDF)

Early prostate cancer – which treatment do men prefer and why?

BJU international, 2011-06, Vol.107 (11), p.1762-1768

2011

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(246)

Publikationsform

Sprache

Englisch
(306)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer

Importance of non‐regional lymph nodes in assigning risk in primary metastatic prostate cancer

Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer

Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data

FTIR microscopy of biological cells and tissue: data analysis using resonant Mie scattering (RMieS) EMSC algorithm

Following the Narrow Path

Measurement of elastic properties of prostate cancer cells using AFM

Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer

Automated quantitative high-throughput multiplex immunofluorescence pipeline to evaluate OXPHOS defects in formalin-fixed human prostate tissue

This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial

Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial

Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)

Treatment-related toxicity in men who received Intensity-modulated versus 3D-conformal radiotherapy after radical prostatectomy: A national population-based study

Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study

Assessment of paraffin removal from prostate FFPE sections using transmission mode FTIR-FPA imaging

Accumulation of copy number alterations and clinical progression across advanced prostate cancer

Direct evidence of lipid translocation between adipocytes and prostate cancer cells with imaging FTIR microspectroscopy

Early prostate cancer – which treatment do men prefer and why?

Suchergebnisse filtern